Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

OBJECTIVE: To assess the utility and safety of rituximab in pediatric autoimmune and inflammatory disorders of the CNS. METHODS: Multicenter retrospective study. RESULTS: A total of 144 children and adolescents (median age 8 years, range 0.7–17; 103 female) with NMDA receptor (NMDAR) encephalitis (n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dale, Russell C., Brilot, Fabienne, Duffy, Lisa V., Twilt, Marinka, Waldman, Amy T., Narula, Sona, Muscal, Eyal, Deiva, Kumaran, Andersen, Erik, Eyre, Michael R., Eleftheriou, Despina, Brogan, Paul A., Kneen, Rachel, Alper, Gulay, Anlar, Banu, Wassmer, Evangeline, Heineman, Kirsten, Hemingway, Cheryl, Riney, Catherine J., Kornberg, Andrew, Tardieu, Marc, Stocco, Amber, Banwell, Brenda, Gorman, Mark P., Benseler, Susanne M., Lim, Ming
Format: Artigo
Sprache:Inglês
Veröffentlicht: Lippincott Williams & Wilkins 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4117174/
https://ncbi.nlm.nih.gov/pubmed/24920861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000570
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge